E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers N > Headlines for Nanostring Technologies, Inc. > News item
Published on 3/22/2024 in the Prospect News Distressed Debt Daily.

NanoString reports $16.47 million net loss for February

By Sarah Lizee

Olympia, Wash., March 22 – NanoString Technologies, Inc. reported a $16.47 million net loss for February on $7.05 million gross income/sales, according to a monthly operating report filed Thursday with the U.S. Bankruptcy Court for the District of Delaware.

Its cash balance at the end of the month was $12.77 million.

NanoString Technologies is a Seattle-based biotech company specializing in cancer diagnostic tools. The company filed bankruptcy on Feb. 4 under Chapter 11 case number 24-10160.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.